Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism GSNOR inhibitors(S-nitrosoglutathione reductase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Asthma | Preclinical | US | 29 Aug 2024 | |
Heart Diseases | Preclinical | US | 29 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Preclinical | US | 29 Aug 2024 | |
Inflammation | Preclinical | US | 29 Aug 2024 | |
Nonalcoholic Steatohepatitis | Preclinical | US | 29 Aug 2024 |